Live feed06:30:00·2hPRReleasevia QuantisnowArtiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026ByQuantisnow·Wall Street's wire, on your screen.ARTV· Artiva Biotherapeutics Inc.Health Care
